Altria Science Logo
ALCS Logo

Food and Drug Law Institute Annual Conference 2023

Silver microphone on a black stand with an out of focus blue background

In May, Dr. Sarkar participated on a panel at the Food & Drug Law Institute’s (FDLI) Annual Conference discussing with other experts the role oral tobacco products can play in advancing harm reduction for adults who smoke.

Dr. Sarkar’s presentation focused on harm reduction opportunity for oral tobacco products, including on!. Specifically, Dr. Sarkar discussed:

  • Scientific data demonstrating that on! meets FDA’s standard of “Appropriate for the Protection of Public Health”
  • The role of flavors as a motivator to switch for adults who smoke
  • The need to provide accurate and truthful information on nicotine and relative risk between combustible and smoke-free products

“In order to realize harm reduction, we need to consider the whole portfolio [of tobacco products] and these need to be FDA authorized products. We need to make sure the accurate risk differential is communicated. It needs to be done consistently and there should be a unified public health message to people who smoke who are looking for alternatives. It is an urgent need to take action.”

You can view Dr. Sarkar’s presentation here.